Patents by Inventor Timothy Whitaker

Timothy Whitaker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR INHIBITING ALPHA-SYNUCLEIN AGGREGATION
    Publication number: 20240025953
    Abstract: Provided herein are methods and compositions useful for the treatment of neurodegenerative diseases that include adeno-associated viral vectors that encode one or more peptides that inhibit ?-synuclein aggregation. Such peptides are useful for treating neurodegenerative diseases such as Alzheimer's disease, a Lewy body disorder, Parkinson's disease (PD), PD with dementia (PDD), pure autonomic failure (PAF), and multiple system atrophy (MSA).
    Type: Application
    Filed: September 23, 2021
    Publication date: January 25, 2024
    Inventors: Raj Mehra, Timothy Whitaker
  • PHARMACOKINETICS OF NMDA RECEPTOR ANTAGONISTS
    Publication number: 20230321007
    Abstract: The present disclosure relates to compositions comprising racemic ketamine, or a pharmaceutically acceptable salt thereof, for use in treating psychiatric disorders such as suicidality, suicidal ideation, major depressive disorder, treatment-resistant depression, and post-traumatic stress disorder.
    Type: Application
    Filed: April 11, 2023
    Publication date: October 12, 2023
    Inventors: Raj Mehra, Timothy Whitaker
  • REDUCED SEDATION AND DISSOCIATION IN TREATING NEUROLOGICAL DISORDERS
    Publication number: 20230270694
    Abstract: The present disclosure relates to compositions comprising racemic ketamine, or a pharmaceutically acceptable salt thereof, for use in treating psychiatric disorders such as suicidality, suicidal ideation, major depressive disorder, treatment-resistant depression, and post-traumatic stress disorder.
    Type: Application
    Filed: April 11, 2023
    Publication date: August 31, 2023
    Inventors: Raj Mehra, Timothy Whitaker
  • METHODS OF TREATING SUICIDALITY
    Publication number: 20230241008
    Abstract: The present disclosure relates to compositions comprising racemic ketamine, or a pharmaceutically acceptable salt thereof, for use in treating psychiatric disorders such as suicidality, suicidal ideation, major depressive disorder, treatment-resistant depression, and post-traumatic stress disorder.
    Type: Application
    Filed: April 11, 2023
    Publication date: August 3, 2023
    Inventors: Raj Mehra, Timothy Whitaker
  • REDUCING SIDE EFFECTS OF NMDA ANTAGONISTS
    Publication number: 20230064327
    Abstract: The present disclosure relates to compositions comprising racemic ketamine, or a pharmaceutically acceptable salt thereof, for use in treating psychiatric disorders such as suicidality, suicidal ideation, major depressive disorder, treatment-resistant depression, and post-traumatic stress disorder.
    Type: Application
    Filed: January 22, 2021
    Publication date: March 2, 2023
    Inventors: Raj Mehra, Timothy Whitaker
  • Compositions and methods of treating cognitive impairment
    Patent number: 11253490
    Abstract: The present invention relates generally method of treating or alleviating cognitive impairment by administering an abuse-deterrent formulation containing dextroamphetamine sulfate.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: February 22, 2022
    Assignee: Vallon Pharamaceuticals, Inc.
    Inventors: Ofir Levi, David Baker, Timothy Whitaker